Throughout the challenges of recent months, we’ve continued to safely serve investors’ needs. We are thoughtfully evaluating our office openings and in-person appointments. Learn More
Total contributions top $4.8 million for research, care and support
ST. LOUIS, Jan., 2018 – Edward Jones has surpassed its annual fundraising goal for the Alzheimer’s Association. As a strategic partner and the first national presenting sponsor for the Association’s annual Walk to End Alzheimer's®, Edward Jones raised more than $2.3 million in 2017 through its 2,752 teams across the country. The firm’s total contributions in support of the strategic alliance last year topped $4.8 million.
The Walk to End Alzheimer’s® is the world’s largest event to raise awareness and money for Alzheimer’s care, support and research.
"Our associates have taken the cause of the Walk to End Alzheimer's to heart, as this disease affects our families and our clients in ways that can be devastating,” said John Beuerlein, the principal leading the Edward Jones Senior Investor Council. “We're proud that Edward Jones has a culture of caring that empowers and supports all of us to work together to make a difference in the communities where we live and work."
The strategic alliance, which began in 2016, has several facets. The Alzheimer’s Association has worked with Edward Jones to create the Edward Jones Alzheimer’s Research Fund, a targeted effort to accelerate research on treatment methods, prevention, and, ultimately, a cure. The Alzheimer’s Association also provides educational programs for Edward Jones associates so they can share resources with clients.
"Over the past two years, the incredible efforts by Edward Jones have enabled the Alzheimer’s Association to fund additional research and expand its outreach to help and support more families seeking information, support and guidance around this life-changing disease,” said Donna McCullough, Chief Development Officer, Alzheimer's Association. “We look forward to the future and the progress we can achieve together."
Alzheimer’s disease is the nation’s sixth-leading cause of death, and the only disease among the top 10 causes that cannot be prevented, cured or even slowed, according to the Alzheimer's Association. In the United States alone, more than 5 million people are living with the terminal brain disease, and this number is set to skyrocket to nearly 14 million by 2050 unless more effective treatments are found.
Edward Jones, a Fortune 500 company headquartered in St. Louis, provides financial services in the U.S. and through our affiliate in Canada. Every aspect of our business, from the investments we offer to the location of our branch offices, caters to individual investors. Our 15,000-plus financial advisors serve more than 7 million clients and care for more than $1 trillion in assets. Visit us at www.edwardjones.com. Our recruiting website is www.careers.edwardjones.com. Member SIPC.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. It is the largest nonprofit funder of Alzheimer's research. The Association's mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Its vision is a world without Alzheimer's. Visit www.alz.org or call 800-272-3900.